Clinical trial
Real-World Evidence (RWE) Data Analysis of 3-year Usage of Nerivio, a Remote Electrical Neurostimulation (REN) Device In Patients With Migraine
NCT06738056 is registered in ClinicalTrials.gov with Theranica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Evidence (RWE) Data Analysis of 3-year Usage of Nerivio, a Remote Electrical Neurostimulation (REN) Device In Patients With Migraine
- Lead sponsor
- Theranica
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2024
- Completion date
- December 22, 2024
- Enrollment
- 244 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute treatment of migraine, migraine